IBDEI0C2 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16079,0)
 ;;=V10.04^^98^880^70
 ;;^UTILITY(U,$J,358.3,16079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16079,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,16079,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,16079,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,16080,0)
 ;;=V10.47^^98^880^71
 ;;^UTILITY(U,$J,358.3,16080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16080,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,16080,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,16080,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,16081,0)
 ;;=V10.83^^98^880^69
 ;;^UTILITY(U,$J,358.3,16081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16081,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,16081,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,16081,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,16082,0)
 ;;=285.22^^98^880^9
 ;;^UTILITY(U,$J,358.3,16082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16082,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,16082,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,16082,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16083,0)
 ;;=285.21^^98^880^10
 ;;^UTILITY(U,$J,358.3,16083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16083,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,16083,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,16083,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,16084,0)
 ;;=285.29^^98^880^11
 ;;^UTILITY(U,$J,358.3,16084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16084,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,16084,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,16084,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,16085,0)
 ;;=284.9^^98^880^13
 ;;^UTILITY(U,$J,358.3,16085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16085,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,16085,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,16085,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,16086,0)
 ;;=282.61^^98^880^75
 ;;^UTILITY(U,$J,358.3,16086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16086,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,16086,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,16086,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,16087,0)
 ;;=282.7^^98^880^74
 ;;^UTILITY(U,$J,358.3,16087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16087,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,16087,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,16087,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,16088,0)
 ;;=283.9^^98^880^77
 ;;^UTILITY(U,$J,358.3,16088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16088,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,16088,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,16088,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,16089,0)
 ;;=283.0^^98^880^78
 ;;^UTILITY(U,$J,358.3,16089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16089,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,16089,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,16089,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,16090,0)
 ;;=282.9^^98^880^76
 ;;^UTILITY(U,$J,358.3,16090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16090,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,16090,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,16090,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,16091,0)
 ;;=283.19^^98^880^79
 ;;^UTILITY(U,$J,358.3,16091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16091,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,16091,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,16091,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,16092,0)
 ;;=280.9^^98^880^83
 ;;^UTILITY(U,$J,358.3,16092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16092,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,16092,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,16092,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,16093,0)
 ;;=285.1^^98^880^81
 ;;^UTILITY(U,$J,358.3,16093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16093,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,16093,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,16093,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,16094,0)
 ;;=280.0^^98^880^82
 ;;^UTILITY(U,$J,358.3,16094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16094,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,16094,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chr Blood Loss
 ;;^UTILITY(U,$J,358.3,16094,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,16095,0)
 ;;=281.9^^98^880^101
 ;;^UTILITY(U,$J,358.3,16095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16095,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,16095,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,16095,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,16096,0)
 ;;=281.0^^98^880^121
 ;;^UTILITY(U,$J,358.3,16096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16096,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,16096,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,16096,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,16097,0)
 ;;=282.60^^98^880^108
 ;;^UTILITY(U,$J,358.3,16097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16097,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,16097,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,16097,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,16098,0)
 ;;=282.62^^98^880^109
 ;;^UTILITY(U,$J,358.3,16098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16098,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,16098,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,16098,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,16099,0)
 ;;=281.1^^98^880^122
 ;;^UTILITY(U,$J,358.3,16099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16099,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,16099,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,16099,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,16100,0)
 ;;=286.7^^98^880^51
 ;;^UTILITY(U,$J,358.3,16100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16100,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,16100,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,16100,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,16101,0)
 ;;=289.9^^98^880^118
 ;;^UTILITY(U,$J,358.3,16101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16101,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,16101,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,16101,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,16102,0)
 ;;=451.9^^98^880^119
 ;;^UTILITY(U,$J,358.3,16102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16102,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,16102,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,16102,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,16103,0)
 ;;=446.6^^98^880^120
 ;;^UTILITY(U,$J,358.3,16103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16103,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,16103,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,16103,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,16104,0)
 ;;=286.4^^98^880^123
 ;;^UTILITY(U,$J,358.3,16104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16104,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,16104,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,16104,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,16105,0)
 ;;=204.00^^98^880^2
 ;;^UTILITY(U,$J,358.3,16105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16105,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,16105,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,16105,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,16106,0)
 ;;=204.01^^98^880^1
 ;;^UTILITY(U,$J,358.3,16106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16106,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,16106,1,5,0)
 ;;=5^ALL in Remission
 ;;^UTILITY(U,$J,358.3,16106,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,16107,0)
 ;;=204.10^^98^880^26
 ;;^UTILITY(U,$J,358.3,16107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16107,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,16107,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,16107,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,16108,0)
 ;;=204.11^^98^880^24
 ;;^UTILITY(U,$J,358.3,16108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16108,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,16108,1,5,0)
 ;;=5^CLL in Remission
 ;;^UTILITY(U,$J,358.3,16108,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,16109,0)
 ;;=202.41^^98^880^73
 ;;^UTILITY(U,$J,358.3,16109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16109,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,16109,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,16109,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,16110,0)
 ;;=201.90^^98^880^80
 ;;^UTILITY(U,$J,358.3,16110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16110,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,16110,1,5,0)
 ;;=5^Hodgkin's Lymphoma,Unspec Type & Site
 ;;^UTILITY(U,$J,358.3,16110,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,16111,0)
 ;;=785.6^^98^880^86
 ;;^UTILITY(U,$J,358.3,16111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16111,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,16111,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,16111,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,16112,0)
 ;;=200.20^^98^880^89
 ;;^UTILITY(U,$J,358.3,16112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16112,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,16112,1,5,0)
 ;;=5^Lymphoma,Burkett's,Unspecified Sites
 ;;^UTILITY(U,$J,358.3,16112,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,16113,0)
 ;;=202.00^^98^880^88
 ;;^UTILITY(U,$J,358.3,16113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16113,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,16113,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,16113,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,16114,0)
 ;;=200.10^^98^880^87
 ;;^UTILITY(U,$J,358.3,16114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16114,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,16114,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,16114,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,16115,0)
 ;;=273.3^^98^880^90
 ;;^UTILITY(U,$J,358.3,16115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16115,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,16115,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,16115,2)
 ;;=^73013
